Love, R. (2021) “By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer”, Archives of Breast Cancer, pp. 8-13. doi: 10.32768/abc.2021818-13.